Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-21,400
Closed -$42.6K 3086
2025
Q2
$42.6K Buy
+21,400
New +$39.1K ﹤0.01% 2607

Marshall Wace's HLVX Position: Q3 2025 in Review

Marshall Wace sold out of HilleVax (HLVX) in Q3 2025, closing a stake of 21,400 shares — an estimated $42.6K sold.

Marshall Wace first reported a position in HLVX in Q2 2025 and held it in 1 quarter. The position peaked at $42.6K in Q2 2025. 1 fund tracked by Wall St. Rank holds HLVX as of Q3 2025.

  • Marshall Wace reported no remaining HilleVax position as of Q3 2025 after selling out during the quarter.
  • Marshall Wace sold 21,400 HilleVax shares in Q3 2025, an estimated $42.6K.
  • Marshall Wace first reported a position in HilleVax in Q2 2025 and held it in 1 quarter.
  • Marshall Wace's HilleVax position peaked at $42.6K in Q2 2025.
  • 1 fund tracked by Wall St. Rank held HilleVax as of Q3 2025.

Based on Marshall Wace's 13F filing for Q3 2025, filed 13 Nov 2025.